Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Top-Institutions - MDSpire

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

  • By

  • Chengqian Chen

  • Wei Guo

  • Xiaoyu Song

  • Xin Wan

  • Zhaoxia Li

  • Haotian Wang

  • Ou Bai

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Rochester Medical Center
    University of Rochester Medical Center

    Rochester, NY

    Key Differentiators

    • Hematology

  • #2

    SWOG Cancer Research Network
    SWOG Cancer Research Network

    Seattle, WA

    Key Differentiators

    • Cancer Research

  • #3

    Fred Hutch Cancer Center
    Fred Hutch Cancer Center

    Seattle, WA

    Key Differentiators

    • Cancer Research

  • #4

    Emory University School of Medicine
    Emory University School of Medicine

    Atlanta, GA

    Key Differentiators

    • Hematology

  • #5

    German Hodgkin Study Group
    German Hodgkin Study Group

    Heidelberg, Germany

    Key Differentiators

    • Hematology

Original Source(s)

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

  • by Chengqian Chen, Wei Guo, Xiaoyu Song, Xin Wan, Zhaoxia Li, Haotian Wang, Ou Bai

  • May 29, 2026

Related Content

High-grade astrocytoma with piloid features: a case report of comprehensive management

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant